Literature DB >> 17000701

A whole MEN1 gene deletion flanked by Alu repeats in a family with multiple endocrine neoplasia type 1.

Atsushi Fukuuchi1, Yuko Nagamura, Hiroko Yaguchi, Naganari Ohkura, Takao Obara, Toshihiko Tsukada.   

Abstract

Multiple endocrine neoplasia type 1 is an autosomal dominant cancer syndrome characterized by pituitary, parathyroid and enteropancreatic endocrine tumors, which is caused by germline mutations of the tumor suppressor gene MEN1. In the case reported here, the patient had family with this disease whose germline MEN1 mutation was undetectable by conventional sequencing analysis. Further investigations involving polymorphism analyses, gene dose assay and nucleotide sequencing identified a large germline deletion of approximately 29 kilobase pairs spanning the whole MEN1 gene. The deletion was flanked by Alu repetitive sequences, suggesting unequal homologous recombination as the deletion mechanism. The polymorphism linkage data suggested that an asymptomatic son of the proband did not carry the family mutation. More direct evidence was obtained by gene dose assay and deletion-specific polymerase chain reaction, which demonstrated the normal MEN1 gene dosage and the absence of the deletion breakpoints in this asymptomatic subject and thus definitely excluded the possibility of disease predisposition.

Entities:  

Mesh:

Year:  2006        PMID: 17000701     DOI: 10.1093/jjco/hyl089

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  9 in total

Review 1.  An alternative approach to medical genetics based on modern evolutionary biology. Part 4: HERVs in cancer.

Authors:  Frank P Ryan
Journal:  J R Soc Med       Date:  2009-11       Impact factor: 5.344

2.  A novel C-terminal nonsense mutation, Q315X, of the aryl hydrocarbon receptor-interacting protein gene in a Japanese familial isolated pituitary adenoma family.

Authors:  Takeo Iwata; Shozo Yamada; Junko Ito; Naoko Inoshita; Noriko Mizusawa; Shinji Ono; Katsuhiko Yoshimoto
Journal:  Endocr Pathol       Date:  2014-09       Impact factor: 3.943

Review 3.  Hyperparathyroid genes: sequences reveal answers and questions.

Authors:  Stephen J Marx
Journal:  Endocr Pract       Date:  2011 Jul-Aug       Impact factor: 3.443

4.  Homozygous deletion of the STK11/LKB1 locus and the generation of novel fusion transcripts in cervical cancer cells.

Authors:  Michael T McCabe; Doris R Powell; Wei Zhou; Paula M Vertino
Journal:  Cancer Genet Cytogenet       Date:  2010-03

Review 5.  A mobile threat to genome stability: The impact of non-LTR retrotransposons upon the human genome.

Authors:  Miriam K Konkel; Mark A Batzer
Journal:  Semin Cancer Biol       Date:  2010-03-20       Impact factor: 15.707

6.  Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression.

Authors:  Maria Chiara Zatelli; Federico Tagliati; Mauro Di Ruvo; Emilie Castermans; Luigi Cavazzini; Adrian F Daly; Maria Rosaria Ambrosio; Albert Beckers; Ettore degli Uberti
Journal:  Fam Cancer       Date:  2014-06       Impact factor: 2.375

7.  Genetic screening for multiple endocrine neoplasia syndrome type 1 (MEN-1): when and how.

Authors:  Alberto Falchetti
Journal:  F1000 Med Rep       Date:  2010-02-24

8.  Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).

Authors:  Elena Pardi; Stefano Mariotti; Natalia S Pellegata; Katiuscia Benfini; Simona Borsari; Federica Saponaro; Liborio Torregrossa; Antonello Cappai; Chiara Satta; Marco Mastinu; Claudio Marcocci; Filomena Cetani
Journal:  Endocr Connect       Date:  2014-11-21       Impact factor: 3.335

9.  Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.

Authors:  Elena Pardi; Simona Borsari; Federica Saponaro; Fausto Bogazzi; Claudio Urbani; Stefano Mariotti; Francesca Pigliaru; Chiara Satta; Fabiana Pani; Gabriele Materazzi; Paolo Miccoli; Lorena Grantaliano; Claudio Marcocci; Filomena Cetani
Journal:  PLoS One       Date:  2017-10-16       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.